NASDAQ:THRM - US37253A1034 - Common Stock
The current stock price of THRM is 35.77 USD. In the past month the price increased by 9.42%. In the past year, price decreased by -25.14%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
APTV | APTIV PLC | 11.13 | 17.89B | ||
MGA | MAGNA INTERNATIONAL INC | 8.86 | 12.96B | ||
MBLY | MOBILEYE GLOBAL INC-A | 33.86 | 12.13B | ||
ALV | AUTOLIV INC | 13.6 | 9.64B | ||
BWA | BORGWARNER INC | 9.88 | 9.45B | ||
MOD | MODINE MANUFACTURING CO | 34.03 | 7.27B | ||
GNTX | GENTEX CORP | 15.25 | 6.19B | ||
LEA | LEAR CORP | 8.94 | 5.91B | ||
DORM | DORMAN PRODUCTS INC | 19.81 | 4.98B | ||
QS | QUANTUMSCAPE CORP | N/A | 4.83B | ||
HSAI | HESAI GROUP | 137.1 | 3.81B | ||
PATK | PATRICK INDUSTRIES INC | 26.45 | 3.72B |
Gentherm, Inc. engages in the design, development, manufacturing, and marketing of heating, cooling, and ventilating devices. The company is headquartered in Novi, Michigan and currently employs 14,246 full-time employees. The firm operates in two segments: Automotive and Medical. The Automotive reporting segment comprises global automotive businesses, including the design, development, manufacturing and sales of its automotive climate and comfort solutions (including Climate Control Seats, Climate Control Interiors, lumbar and massage comfort solutions and electronic solutions for climate and comfort technologies), valve system solutions and other automotive products. The Medical reporting segment comprises the patient temperature management business in the medical industry. Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and additional warming/cooling therapies utilized in acute and chronic care departments and non-hospital facilities.
GENTHERM INC
28875 Cabot Drive
Novi MICHIGAN 48167 US
CEO: PHILLIP EYLER
Employees: 14246
Phone: 12485040500
The current stock price of THRM is 35.77 USD. The price decreased by -1.87% in the last trading session.
The exchange symbol of GENTHERM INC is THRM and it is listed on the Nasdaq exchange.
THRM stock is listed on the Nasdaq exchange.
12 analysts have analysed THRM and the average price target is 44.63 USD. This implies a price increase of 24.76% is expected in the next year compared to the current price of 35.77. Check the GENTHERM INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
GENTHERM INC (THRM) has a market capitalization of 1.09B USD. This makes THRM a Small Cap stock.
GENTHERM INC (THRM) currently has 14246 employees.
GENTHERM INC (THRM) has a support level at 35.76 and a resistance level at 35.9. Check the full technical report for a detailed analysis of THRM support and resistance levels.
The Revenue of GENTHERM INC (THRM) is expected to decline by -0.87% in the next year. Check the estimates tab for more information on the THRM EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
THRM does not pay a dividend.
GENTHERM INC (THRM) will report earnings on 2025-10-28, before the market open.
The PE ratio for GENTHERM INC (THRM) is 17.11. This is based on the reported non-GAAP earnings per share of 2.09 and the current share price of 35.77 USD. Check the full fundamental report for a full analysis of the valuation metrics for THRM.
The outstanding short interest for GENTHERM INC (THRM) is 2.2% of its float. Check the ownership tab for more information on the THRM short interest.
ChartMill assigns a technical rating of 8 / 10 to THRM. When comparing the yearly performance of all stocks, THRM turns out to be only a medium performer in the overall market: it outperformed 44.72% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to THRM. While THRM has a great health rating, there are worries on its profitability.
Over the last trailing twelve months THRM reported a non-GAAP Earnings per Share(EPS) of 2.09. The EPS decreased by -25.89% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 2.18% | ||
ROA | 2.32% | ||
ROE | 4.52% | ||
Debt/Equity | 0.3 |
12 analysts have analysed THRM and the average price target is 44.63 USD. This implies a price increase of 24.76% is expected in the next year compared to the current price of 35.77.
For the next year, analysts expect an EPS growth of -1.88% and a revenue growth -0.87% for THRM